-
IPO Watch: Sudeep Pharma files draft papers with SEBI to raise funds via IPO
25 Jun 2025 13:57 GMT
… (SEBI), for an initial public offering (IPO).
Sudeep Pharma, since … notable clients such as Pfizer Inc, Intas Pharmaceuticals Limited … 54 crore, respectively.
The initial public offering (IPO), with a nominal value … crore as a pre-IPO placement, which shall …
-
Sudeep Pharma files draft papers with Sebi to mop up funds via IPO
25 Jun 2025 11:44 GMT
… funds through an initial public offering (IPO).
The IPO is a combination … company plans a pre-IPO placement of shares aggregating … crore. If the pre-IPO placement is completed, … with marquee customers, including Pfizer, Intas Pharmaceuticals, Mankind Pharma …
-
Precision Medicine Firm Caris Breaks Bio IPO Drought, Raising $494M for Cancer Analysis Tools
22 Jun 2025 22:43 GMT
… Merck immunotherapy Keytruda and the Pfizer kinase inhibitor Braftovi. This … any significant portion of IPO proceeds, other than general … raised across 13 healthcare IPOs through May, according to … beyond their IPO prices last week, which IPO research firm …
-
China Market Update: Easing Cycle Continues As CATL IPO & 3SBio Jump
20 May 2025 15:10 GMT
… Kong initial public offering, the largest globally so far this year. The robust IPO … announcing a licensing agreement with Pfizer for its cancer drug. The …
-
Fierce Pharma Asia—Pfizer partner's trial win; Roche's $300M China plant; Hengrui's HK IPO plan
16 May 2025 18:00 GMT
… in its Hong Kong IPO. And more.
1. Pfizer partner RemeGen says … diagnosed bladder cancer
RemeGen’s Pfizer-partnered HER2 antibody-drug … trial win bodes well for Pfizer’s global DV-001 … $1.27B in Hong Kong IPO (Morningstar)
Jiangsu Hengrui Pharmaceutical, …
-
NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO
07 May 2025 18:50 GMT
… of the company’s future IPO.
Burdick is a seasoned public … , he spent 13 years at Pfizer, Inc., serving as Group Director … of Specialty Hospital Services for Pfizer Animal Health. Dr. McFarland earned …
-
Rx Rundown: Royalty Pharma, Gilead Sciences, Abridge and more
27 Jun 2025 13:21 GMT
… Biotech filed for a proposed initial public offering.
Layoffs:
Leap Therapeutics laid off … .
Opella achieved B Corp Certification.
Pfizer‘s hemophilia drug Hympavzi notched …
-
Safety worries spur Pfizer to drop another obesity pill
14 Apr 2025 23:59 GMT
… In a statement, Chris Boshoff, Pfizer’s top scientist, said the … development, the company said.
Pfizer still has other candidates in … among Wall Street analysts that Pfizer might turn to deals … raise $275 million in an initial public offering in January.
-
Why The Crypto Market Excitement About An IPO Wave Faded
17 Apr 2025 15:12 GMT
Eli Lilly (LLY) stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds over the course of 40 weeks.
The news solidifies Lilly's lead in developing an oral treatment for obesity. It …
-
Pfizer Halts Development Of Oral Weight-Loss Pill After Liver Injury Case In Patient
14 Apr 2025 13:18 GMT
… the medication was stopped.
Pfizer had been testing multiple … however, developed liver injury.
Pfizer said that “after a … of investigational treatments," Pfizer’s chief scientific officer, … trends, stock updates, tax, IPO, banking finance, real estate, …